Your browser doesn't support javascript.
loading
Costs and Causes of Oncology Drug Attrition With the Example of Insulin-Like Growth Factor-1 Receptor Inhibitors.
Jentzsch, Valerie; Osipenko, Leeza; Scannell, Jack W; Hickman, John A.
Affiliation
  • Jentzsch V; London School of Economics, London, United Kingdom.
  • Osipenko L; London School of Economics, London, United Kingdom.
  • Scannell JW; Consilium Scientific, London, United Kingdom.
  • Hickman JA; Science, Technology, and Innovation Studies, University of Edinburgh, Edinburgh, United Kingdom.
JAMA Netw Open ; 6(7): e2324977, 2023 07 03.
Article in En | MEDLINE | ID: mdl-37505498
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Insulin-Like Growth Factor I / Neoplasms Type of study: Etiology_studies / Guideline / Health_economic_evaluation / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: JAMA Netw Open Year: 2023 Type: Article Affiliation country: United kingdom
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Insulin-Like Growth Factor I / Neoplasms Type of study: Etiology_studies / Guideline / Health_economic_evaluation / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: JAMA Netw Open Year: 2023 Type: Article Affiliation country: United kingdom